FR2840217B1 - Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations - Google Patents

Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations

Info

Publication number
FR2840217B1
FR2840217B1 FR0206796A FR0206796A FR2840217B1 FR 2840217 B1 FR2840217 B1 FR 2840217B1 FR 0206796 A FR0206796 A FR 0206796A FR 0206796 A FR0206796 A FR 0206796A FR 2840217 B1 FR2840217 B1 FR 2840217B1
Authority
FR
France
Prior art keywords
dsrna
double
stranded rna
cosmetic compositions
rna oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0206796A
Other languages
English (en)
Other versions
FR2840217A1 (fr
Inventor
Albert Duranton
Djangone Christine Collin
Francis Pruche
Jean Thierry Simmonet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0206796A priority Critical patent/FR2840217B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to JP2004508734A priority patent/JP4499554B2/ja
Priority to EP03756039A priority patent/EP1513482B1/fr
Priority to DE60332112T priority patent/DE60332112D1/de
Priority to AU2003255621A priority patent/AU2003255621A1/en
Priority to AT03756039T priority patent/ATE464038T1/de
Priority to PCT/FR2003/001648 priority patent/WO2003101376A2/fr
Priority to ES03756039T priority patent/ES2342826T3/es
Priority to CA002485111A priority patent/CA2485111A1/fr
Publication of FR2840217A1 publication Critical patent/FR2840217A1/fr
Priority to US11/001,085 priority patent/US20050222071A1/en
Application granted granted Critical
Publication of FR2840217B1 publication Critical patent/FR2840217B1/fr
Priority to US12/007,387 priority patent/US9012418B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0206796A 2002-06-03 2002-06-03 Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations Expired - Fee Related FR2840217B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0206796A FR2840217B1 (fr) 2002-06-03 2002-06-03 Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations
CA002485111A CA2485111A1 (fr) 2002-06-03 2003-06-02 Utilisation par voie topique d'au moins un oligonucleotide d'arn double brin (ds rna)
DE60332112T DE60332112D1 (de) 2002-06-03 2003-06-02 Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase
AU2003255621A AU2003255621A1 (en) 2002-06-03 2003-06-02 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
AT03756039T ATE464038T1 (de) 2002-06-03 2003-06-02 Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase
PCT/FR2003/001648 WO2003101376A2 (fr) 2002-06-03 2003-06-02 Utilisation par voie topique d'au moins un oligonucleotide d'arn double brin (ds rna)
JP2004508734A JP4499554B2 (ja) 2002-06-03 2003-06-02 少なくとも１つの二本鎖ＲＮＡオリゴヌクレオチド（ｄｓＲＮＡ）の局所的使用
EP03756039A EP1513482B1 (fr) 2002-06-03 2003-06-02 Utilisation par voie topique d'au moins un oligonucleotide d'arn double brin (ds rna) anti-tyrosinase
ES03756039T ES2342826T3 (es) 2002-06-03 2003-06-02 Utilizacion por via topica de al menos un oligonucleotido de arn de doble helice (dsrna) anti-tirosina.
US11/001,085 US20050222071A1 (en) 2002-06-03 2004-12-02 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA)
US12/007,387 US9012418B2 (en) 2002-06-03 2008-01-09 Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0206796A FR2840217B1 (fr) 2002-06-03 2002-06-03 Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations

Publications (2)

Publication Number Publication Date
FR2840217A1 FR2840217A1 (fr) 2003-12-05
FR2840217B1 true FR2840217B1 (fr) 2005-06-24

Family

ID=29558920

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0206796A Expired - Fee Related FR2840217B1 (fr) 2002-06-03 2002-06-03 Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations

Country Status (2)

Country Link
US (2) US20050222071A1 (fr)
FR (1) FR2840217B1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070141009A1 (en) * 2003-01-03 2007-06-21 Shaharyar Khan Sirna mediated post-transriptional gene silencing of genes involved in alopecia
CA2555199A1 (fr) * 2004-02-04 2005-08-18 Yokohama City University Inhibiteur de la peptidyl arginine deiminase de type iv
US9095630B2 (en) * 2005-05-19 2015-08-04 L'oreal Vectorization of dsRNA by cationic particles and use of same on a skin model
US9139850B2 (en) * 2005-05-19 2015-09-22 L'oreal Vectorization of dsRNA by cationic particles and topical use
FR2890859B1 (fr) * 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase
CN101765423B (zh) * 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
US8796443B2 (en) 2008-09-22 2014-08-05 Rxi Pharmaceuticals Corporation Reduced size self-delivering RNAi compounds
US8315815B2 (en) 2008-12-30 2012-11-20 The Invention Science Fund I, Llc Computational methods and systems for suggesting modulators of CYP450 as treatment options
US8073632B2 (en) * 2008-12-30 2011-12-06 The Invention Science Fund I, Llc Computational methods and systems for treatment in relation to modulation of CYP450 enzyme activity
US8321151B2 (en) 2008-12-30 2012-11-27 The Invention Science Fund I, Llc Computational methods and systems for treatment in relation to modulation of CYP450 enzyme activity
KR102453078B1 (ko) 2010-03-24 2022-10-11 피오 파마슈티칼스 코프. 진피 및 섬유증성 적응증에서의 ｒｎａ 간섭
WO2016037071A2 (fr) * 2014-09-05 2016-03-10 Rxi Pharmaceuticals Corporation Méthodes de traitement de troubles cutanés et du vieillissement à l'aide d'acides nucléiques ciblant tyr ou mmp1
WO2016150723A1 (fr) 2015-03-20 2016-09-29 Unilever Plc Composition antisudorifique
FR3043695B1 (fr) * 2015-11-17 2019-10-25 ISP Investments LLC. Procede d'obtention d'un extrait aqueux enrichi en petits arn a partir d'une matiere vegetal et extraits issus du procede
WO2020185685A1 (fr) * 2019-03-08 2020-09-17 The Regents Of The University Of California Compositions et méthodes de traitement de l'acné
WO2020185053A2 (fr) * 2019-03-14 2020-09-17 주식회사 에스엔비아 Bande de micro-aiguilles présentant une activité améliorée pour favoriser la croissance des ongles des doigts et des orteils

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014709A1 (fr) * 1995-10-13 1997-04-24 F. Hoffmann-La Roche Ag Oligomeres antisens
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
GB9927444D0 (en) * 1999-11-19 2000-01-19 Cancer Res Campaign Tech Inhibiting gene expression
FR2804960B1 (fr) * 2000-02-11 2005-06-24 Lvmh Rech Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase- related-protein 1 comme agents depigmentants
US7101995B2 (en) * 2001-08-27 2006-09-05 Mirus Bio Corporation Compositions and processes using siRNA, amphipathic compounds and polycations
US20050002917A1 (en) * 2003-05-07 2005-01-06 Schwartz Lawrence M. Regulation of Acheron expression

Also Published As

Publication number Publication date
US20050222071A1 (en) 2005-10-06
US20090117063A1 (en) 2009-05-07
FR2840217A1 (fr) 2003-12-05
US9012418B2 (en) 2015-04-21

Similar Documents

Publication Publication Date Title
FR2840217B1 (fr) Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations
IL237721B (en) Lipid-wrapped interfering RNA and uses thereof
IT1308627B1 (it) Composizioni fluoroelastomeriche.
IT1308628B1 (it) Composizioni fluoroelastomeriche.
IL166658A0 (en) RNA molecules and pharmaceutical compositions containing the same
AU2002366879A8 (en) Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility
WO2003101376A3 (fr) Utilisation par voie topique d'au moins un oligonucleotide d'arn double brin (ds rna)
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
MXPA03001802A (es) Composicion acondicionadora pre-champu.
ITRM20000494A0 (it) Varianti di allergeni ns-ltps, loro usi e composizioni che le comprendono.
ITTO20010079A0 (it) Composizioni pesticide in forma di gel.
FR2834900B1 (fr) Nouvelles compositions a activite anti-igf-ir et anti-egfr et leurs applications
IT1313700B1 (it) Composizioni anti-incrostazione e loro impiego nei processi dipolimerizzazione.
DE50011959D1 (de) Planarer Abgleichwiderstand, Anwendungen und Verfahren zu seiner Herstellung
DE60319388D1 (de) C6- UND C9-SUBSTITUIERTE CHROMENOÄ4,3-cÜISOXAZOLIN
ITTO20030078A1 (it) Composizioni in particolare per l'impiego con elastomeri.
TH69110S (th) ที่จ่ายสารระเหย
TH92154S (th) ที่จ่ายสารระเหย
DE50114558D1 (de) Gamma korrigiertes Alpha-Blending
ES1053329Y (es) Expositor numismatico.
TH102502S (th) รถโดยสาร
UA7099S (uk) Дисконтна картка
UA6366S (uk) Картка дисконтна
UA4998S (uk) Етикетка «княжна. печиво ромове»
TH87861S (th) โถส้วม

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20220205